Kura Oncology KURA
NASDAQ KURA
$7.73 +0.16 (+2.11%)
At close: Nov 11, 2026 · 4:00 PM EST

Kura Oncology (KURA) Receivables - Net (2024 - 2026)

Updated

Kura Oncology (KURA) reported Receivables - Net of $9.45 million for Q2 2026, up 106.5% from $4.57 million a year earlier and up 1.0% from the prior quarter.

Analysis

Kura Oncology (KURA) Receivables - Net (2024 - 2026) Analysis & Trends

At the end of FY2025, Kura Oncology posted Receivables - Net of $8.8 million, up 327.4% from FY2024.

  • By year, Receivables - Net came in at $2.06 million in FY2024.
  • Five-year quarterly Receivables - Net spans a low of $2.06 million in Q4 2024 and a high of $48.75 million in Q1 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $9.35 million (Q1 2026), $8.8 million (Q4 2025) and $35.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Kura Oncology 695.52 Mn -1.56 Bn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.49 Mn
Jun 30, 2026 9.45 Mn
Mar 31, 2026 9.35 Mn
Dec 31, 2025 8.80 Mn
Sep 30, 2025 35.94 Mn
Jun 30, 2025 4.57 Mn
Mar 31, 2025 48.75 Mn
Dec 31, 2024 2.06 Mn
API Access

Kura Oncology Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=KURA&period=max&api_key=YOUR_API_KEY